Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

June 01, 2004; Volume 309,Issue 3

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Structures and Models of Transporter Proteins
    Svein G. Dahl, Ingebrigt Sylte and Aina Westrheim Ravna
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 853-860; DOI: https://doi.org/10.1124/jpet.103.059972

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

  • You have access
    Pharmacokinetics, Safety, and Efficacy of a Liposome Encapsulated Thymidylate Synthase Inhibitor, OSI-7904L [(S)-2-[5-[(1,2-Dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric Acid] in Mice
    John Desjardins, David L. Emerson, Dorothy B. Colagiovanni, Elizabeth Abbott, Eric N. Brown and Daniel W. Drolet
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 894-902; DOI: https://doi.org/10.1124/jpet.103.064725
  • You have access
    Benzylamine Exhibits Insulin-Like Effects on Glucose Disposal, Glucose Transport, and Fat Cell Lipolysis in Rabbits and Diabetic Mice
    María Carmen Iglesias-Osma, Maria José Garcia-Barrado, Virgile Visentin, Maria Francisca Pastor-Mansilla, Sandy Bour, Danielle Prévot, Philippe Valet, Julio Moratinos and Christian Carpéné
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1020-1028; DOI: https://doi.org/10.1124/jpet.103.063636
  • You have access
    Cyclosporin A, but Not Tacrolimus, Inhibits the Biliary Excretion of Mycophenolic Acid Glucuronide Possibly Mediated by Multidrug Resistance-Associated Protein 2 in Rats
    Mikako Kobayashi, Hiroshi Saitoh, Michiya Kobayashi, Koji Tadano, Yasushi Takahashi and Tetsuo Hirano
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1029-1035; DOI: https://doi.org/10.1124/jpet.103.063073
  • You have access
    Pharmacokinetics of Recombinant Human Leukemia Inhibitory Factor in Sheep
    Alicia M. Segrave, Donald E. Mager, Susan A. Charman, Glenn A. Edwards and Christopher J. H. Porter
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1085-1092; DOI: https://doi.org/10.1124/jpet.103.063289
  • You have access
    2-Hydroxyestradiol Is a Prodrug of 2-Methoxyestradiol
    Lefteris C. Zacharia, Claude A. Piché, Robert M. Fielding, Kathleen M. Holland, S. Dean Allison, Raghvendra K. Dubey and Edwin K. Jackson
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1093-1097; DOI: https://doi.org/10.1124/jpet.103.062505
  • You have access
    Pharmacokinetics and Tissue Distribution of the Stereoisomers of 4-Methylaminorex in the Rat
    Esa Meririnne, Satu Ellermaa, Aino Kankaanpää, Ali Bardy and Timo Seppälä
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1198-1205; DOI: https://doi.org/10.1124/jpet.103.060053
  • You have access
    Multidrug Resistance Protein (MRP) 4- and MRP 5-Mediated Efflux of 9-(2-Phosphonylmethoxyethyl)adenine by Microglia
    Shannon Dallas, Lyanne Schlichter and Reina Bendayan
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1221-1229; DOI: https://doi.org/10.1124/jpet.103.063966
  • You have access
    Mouse Reduced in Osteosclerosis Transporter Functions as an Organic Anion Transporter 3 and Is Localized at Abluminal Membrane of Blood-Brain Barrier
    Sumio Ohtsuki, Tazuru Kikkawa, Shinobu Mori, Satoko Hori, Hitomi Takanaga, Masaki Otagiri and Tetsuya Terasaki
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1273-1281; DOI: https://doi.org/10.1124/jpet.103.063370
  • You have access
    Isolation and Characterization of a New Major Intestinal CYP3A Form, CYP3A62, in the Rat
    T. Matsubara, H. J. Kim, M. Miyata, M. Shimada, K. Nagata and Y. Yamazoe
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1282-1290; DOI: https://doi.org/10.1124/jpet.103.061671

BEHAVIORAL PHARMACOLOGY

  • You have access
    Deletion of the fyn-Kinase Gene Alters Sensitivity to GABAergic Drugs: Dependence on β2/β3 GABAA Receptor Subunits
    Stephen L. Boehm, Laura Peden, R. Adron Harris and Yuri A. Blednov
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1154-1159; DOI: https://doi.org/10.1124/jpet.103.064444
  • You have access
    Effects of Murine-Derived Anti-Methamphetamine Monoclonal Antibodies on (+)-Methamphetamine Self-Administration in the Rat
    D. E. McMillan, W. C. Hardwick, M. Li, M. G. Gunnell, F. I. Carroll, P. Abraham and S. M. Owens
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1248-1255; DOI: https://doi.org/10.1124/jpet.103.061762

CARDIOVASCULAR

  • You have access
    Coadministration of a Liver X Receptor Agonist and a Peroxisome Proliferator Activator Receptor-α Agonist in Mice: Effects of Nuclear Receptor Interplay on High-Density Lipoprotein and Triglyceride Metabolism in Vivo
    Thomas P. Beyer, Robert J. Schmidt, Patricia Foxworthy, Youyan Zhang, Jiannong Dai, William R. Bensch, Raymond F. Kauffman, Hong Gao, Timothy P. Ryan, Xian-Cheng Jiang, Sotirios K. Karathanasis, Patrick I. Eacho and Guoqing Cao
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 861-868; DOI: https://doi.org/10.1124/jpet.103.064535
  • You have access
    A Specific Chymase Inhibitor, 2-(5-Formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), Suppresses Development of Abdominal Aortic Aneurysm in Hamsters
    Koutaro Tsunemi, Shinji Takai, Masayoshi Nishimoto, Denan Jin, Masato Sakaguchi, Michiko Muramatsu, Atsushi Yuda, Shinjiro Sasaki and Mizuo Miyazaki
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 879-883; DOI: https://doi.org/10.1124/jpet.103.063974
  • You have access
    A Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), Potently Decreases Plasma Triglyceride and Glucose Levels and Modifies Lipoprotein Profiles in KK-Ay Mice
    Kenji Kuwabara, Kohji Murakami, Makoto Todo, Tomiyoshi Aoki, Tetsuo Asaki, Masatoshi Murai and Junichi Yano
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 970-977; DOI: https://doi.org/10.1124/jpet.103.064659
  • You have access
    Dual Regulation of Tumor Necrosis Factor-α-Induced CCL2/Monocyte Chemoattractant Protein-1 Expression in Vascular Smooth Muscle Cells by Nuclear Factor-κB and Activator Protein-1: Modulation by Type III Phosphodiesterase Inhibition
    Yung-Ming Chen, Wen-Chih Chiang, Shuei-Liong Lin, Kwan-Dun Wu, Tun-Jun Tsai and Bor-Shen Hsieh
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 978-986; DOI: https://doi.org/10.1124/jpet.103.062620
  • You have access
    Rho/Rho Kinase and Phosphoinositide 3-Kinase Are Parallel Pathways in the Development of Spontaneous Arterial Tone in Deoxycorticosterone Acetate-Salt Hypertension
    Erica A. Wehrwein, Carrie A. Northcott, Robert D. Loberg and Stephanie W. Watts
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1011-1019; DOI: https://doi.org/10.1124/jpet.103.062265
  • You have access
    Ca2+-Activated K+ Channels Underlying the Impaired Acetylcholine-Induced Vasodilation in 2K-1C Hypertensive Rats
    Glaucia E. Callera, Alvaro Yogi, Rita C. Tostes, Luciana V. Rossoni and Lusiane M. Bendhack
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1036-1042; DOI: https://doi.org/10.1124/jpet.103.062810
  • You have access
    Nitric Oxide Inhibits ATP Release from Erythrocytes
    Jeffrey J. Olearczyk, Mary L. Ellsworth, Alan H. Stephenson, Andrew J. Lonigro and Randy S. Sprague
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1079-1084; DOI: https://doi.org/10.1124/jpet.103.064709
  • You have access
    2-Furoyl-LIGRLO-amide: A Potent and Selective Proteinase-Activated Receptor 2 Agonist
    John J. McGuire, Mahmoud Saifeddine, Chris R. Triggle, Kimberly Sun and Morley D. Hollenberg
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1124-1131; DOI: https://doi.org/10.1124/jpet.103.064584
  • You have access
    Buspirone Raises Blood Pressure through Activation of Sympathetic Nervous System and by Direct Activation of α1-Adrenergic Receptors after Severe Hemorrhage
    Patrick Osei-Owusu and Karie E. Scrogin
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1132-1140; DOI: https://doi.org/10.1124/jpet.103.064626
  • You have access
    The Effect of Acute Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11 Inhibition on Plasma Extravasation in the Rat
    Anthony C. Sulpizio, Mark A. Pullen, Richard M. Edwards and David P. Brooks
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1141-1147; DOI: https://doi.org/10.1124/jpet.103.064105
  • You have access
    Potassium Canrenoate, an Aldosterone Receptor Antagonist, Reduces Isoprenaline-Induced Cardiac Fibrosis in the Rat
    Romain Bos, Nathalie Mougenot, Odile Médiani, Paul M. Vanhoutte and Philippe Lechat
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1160-1166; DOI: https://doi.org/10.1124/jpet.103.063388
  • You have access
    The Tyrosine Phosphatase Inhibitor Bis(Maltolato)Oxovanadium Attenuates Myocardial Reperfusion Injury by Opening ATP-Sensitive Potassium Channels
    David A. Liem, Coen C. Gho, Ben C. Gho, Shahla Kazim, Olivier C. Manintveld, Pieter D. Verdouw and Dirk J. Duncker
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1256-1262; DOI: https://doi.org/10.1124/jpet.103.062547
  • You have access
    Glucose-Dependent Enhancement of Spontaneous Phasic Contraction Is Suppressed in Diabetic Mouse Portal Vein: Association with Diacylglycerol-Protein Kinase C Pathway
    Koji Nobe, Hikaru Suzuki, Yasushi Sakai, Hiromi Nobe, Richard J. Paul and Kazutaka Momose
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1263-1272; DOI: https://doi.org/10.1124/jpet.103.062802

CELLULAR AND MOLECULAR

  • You have access
    Anthraquinone Polyamines: Novel Channel Blockers to Study N-Methyl-d-Aspartate Receptors
    Keiko Kashiwagi, Ikuko Tanaka, Maki Tamura, Hiromi Sugiyama, Tadashi Okawara, Masami Otsuka, Thomas N. Sabado, Keith Williams and Kazuei Igarashi
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 884-893; DOI: https://doi.org/10.1124/jpet.103.062042
  • You have access
    Potent and Metabolically Stable Agonists for Protease-Activated Receptor-2: Evaluation of Activity in Multiple Assay Systems in Vitro and in Vivo
    Atsufumi Kawabata, Toru Kanke, Daiki Yonezawa, Tsuyoshi Ishiki, Masako Saka, Mototsugu Kabeya, Fumiko Sekiguchi, Satoko Kubo, Ryotaro Kuroda, Masahiro Iwaki, Kousaku Katsura and Robin Plevin
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1098-1107; DOI: https://doi.org/10.1124/jpet.103.061010
  • You have access
    The Synthetic Ligand of Peroxisome Proliferator-Activated Receptor-γ Ciglitazone Affects Human Glioblastoma Cell Lines
    Nicol Strakova, Jiri Ehrmann, Petr Dzubak, Jan Bouchal and Zdenek Kolar
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1239-1247; DOI: https://doi.org/10.1124/jpet.103.063438

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

  • You have access
    Prodrug Modification Increases Potassium Tricyclo[5.2.1.02,6]-decan-8-yl Dithiocarbonate (D609) Chemical Stability and Cytotoxicity against U937 Leukemia Cells
    Aiping Bai, G. Patrick Meier, Yong Wang, Chiara Luberto, Yusuf A. Hannun and Daohong Zhou
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1051-1059; DOI: https://doi.org/10.1124/jpet.103.064600

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    In Vivo Study on Cross Talk between Inducible Nitric-Oxide Synthase and Cyclooxygenase in Rat Gastric Mucosa: Effect of Cyclooxygenase Activity on Nitric Oxide Production
    Kaname Uno, Yoshihito Iuchi, Junichi Fujii, Hideaki Sugata, Katsunori Iijima, Katsuaki Kato, Tooru Shimosegawa and Tetsuhiko Yoshimura
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 995-1002; DOI: https://doi.org/10.1124/jpet.103.061283
  • You have access
    Signal Transduction Underlying Carbachol-Induced Contraction of Human Urinary Bladder
    Tim Schneider, Charlotte Fetscher, Susanne Krege and Martin C. Michel
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1148-1153; DOI: https://doi.org/10.1124/jpet.103.063735

INFLAMMATION AND IMMUNOPHARMACOLOGY

  • You have access
    Ethanol Causes Inflammation in the Airways by a Neurogenic and TRPV1-Dependent Mechanism
    Marcello Trevisani, David Gazzieri, Francesca Benvenuti, Barbara Campi, Q. Thai Dinh, David A. Groneberg, Michela Rigoni, Xavier Emonds-Alt, Christophe Creminon, Axel Fischer, Pierangelo Geppetti and Selena Harrison
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1167-1173; DOI: https://doi.org/10.1124/jpet.103.064162
  • You have access
    Cooperation between Aspirin-Triggered Lipoxin and Nitric Oxide (NO) Mediates Antiadhesive Properties of 2-(Acetyloxy)benzoic Acid 3-(Nitrooxymethyl)phenyl Ester (NCX-4016) (NO-Aspirin) on Neutrophil-Endothelial Cell Adherence
    Stefano Fiorucci, Eleonora Distrutti, Andrea Mencarelli, Giovanni Rizzo, Anna Rita Di Lorenzo, Monia Baldoni, Piero del Soldato, Antonio Morelli and John L. Wallace
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1174-1182; DOI: https://doi.org/10.1124/jpet.103.063651
  • You have access
    E-Prostanoid (EP)2/EP4 Receptor-Dependent Maturation of Human Monocyte-Derived Dendritic Cells and Induction of Helper T2 Polarization
    Shinichiro Kubo, Hideo Kohka Takahashi, Masao Takei, Hiromi Iwagaki, Tadashi Yoshino, Noriaki Tanaka, Shuji Mori and Masahiro Nishibori
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1213-1220; DOI: https://doi.org/10.1124/jpet.103.062646

NEUROPHARMACOLOGY

  • You have access
    A Newly Identified Role for Superoxide in Inflammatory Pain
    Zhi-Qiang Wang, Frank Porreca, Salvatore Cuzzocrea, Karen Galen, Richard Lightfoot, Emanuela Masini, Carolina Muscoli, Vincenzo Mollace, Michael Ndengele, Harry Ischiropoulos and Daniela Salvemini
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 869-878; DOI: https://doi.org/10.1124/jpet.103.064154
  • You have access
    S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: I. Cellular, Electrophysiological, and Neurochemical Profile in Comparison with Ropinirole
    Mark J. Millan, Didier Cussac, Alain Gobert, Françoise Lejeune, Jean-Michel Rivet, Clotilde Mannoury La Cour, Adrian Newman-Tancredi and Jean-Louis Peglion
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 903-920; DOI: https://doi.org/10.1124/jpet.103.062398
  • You have access
    S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: II. Actions in Rodent, Primate, and Cellular Models of Antiparkinsonian Activity in Comparison to Ropinirole
    Mark J. Millan, Benjamin Di Cara, Michael Hill, Michael Jackson, Jeffrey N. Joyce, Jonathan Brotchie, Steve McGuire, Alan Crossman, Lance Smith, Peter Jenner, Alain Gobert, Jean-Louis Peglion and Mauricette Brocco
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 921-935; DOI: https://doi.org/10.1124/jpet.103.062414
  • You have access
    S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole
    Mark J. Millan, Mauricette Brocco, Mariusz Papp, Florence Serres, Christophe Drieu La Rochelle, Trevor Sharp, Jean-Louis Peglion and Anne Dekeyne
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 936-950; DOI: https://doi.org/10.1124/jpet.103.062463
  • You have access
    Noncompetitive Metabotropic Glutamate5 Receptor Antagonist (E)-2-Methyl-6-styryl-pyridine (SIB1893) Depresses Glutamate Release through Inhibition of Voltage-Dependent Ca2+ Entry in Rat Cerebrocortical Nerve Terminals (Synaptosomes)
    Su-Jane Wang and Talvinder S. Sihra
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 951-958; DOI: https://doi.org/10.1124/jpet.103.064881
  • You have access
    Effects of Dopamine Transporter Inhibitors on Cocaine Self-Administration in Rhesus Monkeys: Relationship to Transporter Occupancy Determined by Positron Emission Tomography Neuroimaging
    Kimberly P. Lindsey, Kristin M. Wilcox, John R. Votaw, Mark M. Goodman, Christophe Plisson, F. Ivy Carroll, Kenner C. Rice and Leonard L. Howell
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 959-969; DOI: https://doi.org/10.1124/jpet.103.060293
  • You have access
    Effects of Alcohols and Anesthetics on Recombinant Voltage-Gated Na+ Channels
    Munehiro Shiraishi and R. Adron Harris
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 987-994; DOI: https://doi.org/10.1124/jpet.103.064063
  • You have access
    In Vitro Characterization of 5-Carboxyl-2,4-di-benzamidobenzoic Acid (NS3763), a Noncompetitive Antagonist of GLUK5 Receptors
    Jeppe K. Christensen, Thomas Varming, Philip K. Ahring, Tino D. Jørgensen and Elsebet Ø. Nielsen
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1003-1010; DOI: https://doi.org/10.1124/jpet.103.062794
  • You have access
    Agonist-Induced Serotonin 2A Receptor Desensitization in the Rat Frontal Cortex and Hypothalamus
    K. J. Damjanoska, B. A. Heidenreich, G. H. Kindel, D. N. D'Souza, Y. Zhang, F. Garcia, G. Battaglia, W. A. Wolf, L. D. Van de Kar and N. A. Muma
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1043-1050; DOI: https://doi.org/10.1124/jpet.103.062067
  • You have access
    Naproxen Reduces Excitotoxic Neurodegeneration in Vivo with an Extended Therapeutic Window
    Janna M. Silakova, James A. Hewett and Sandra J. Hewett
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1060-1066; DOI: https://doi.org/10.1124/jpet.103.063867
  • You have access
    Neuroprotective Effects of a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, 2-{3-[4-(4-Chlorophenyl)-1-piperazinyl] propyl}-4(3H)-quinazolinone (FR255595), in an in Vitro Model of Cell Death and in Mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson's Disease
    Akinori Iwashita, Syunji Yamazaki, Kayoko Mihara, Kouji Hattori, Hirofumi Yamamoto, Junya Ishida, Nobuya Matsuoka and Seitaro Mutoh
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1067-1078; DOI: https://doi.org/10.1124/jpet.103.064642
  • You have access
    Structural Determinants of the Pharmacological Properties of the GABAA Receptor α6 Subunit
    Brandon C. Drafts and Janet L. Fisher
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1108-1115; DOI: https://doi.org/10.1124/jpet.103.064360
  • You have access
    Effects of Galantamine, a Nicotinic Allosteric Potentiating Ligand, on Nicotine-Induced Catecholamine Release in Hippocampus and Nucleus Accumbens of Rats
    Burt M. Sharp, M. Yatsula and Yitong Fu
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1116-1123; DOI: https://doi.org/10.1124/jpet.103.063586
  • You have access
    Ethanol Antagonist Peptides: Structural Specificity without Stereospecificity
    Michael F. Wilkemeyer, Shao-yu Chen, Carrie E. Menkari, Kathleen K. Sulik and Michael E. Charness
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1183-1189; DOI: https://doi.org/10.1124/jpet.103.063818
  • You have access
    Role of α7 Nicotinic Acetylcholine Receptors in the Pressor Response to Intracerebroventricular Injection of Choline: Blockade by Amyloid Peptide Aβ1-42
    Xinyu D. Li and Jerry J. Buccafusco
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1206-1212; DOI: https://doi.org/10.1124/jpet.103.063321
  • You have access
    ReN-1869 [(R)-1-(3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-propyl)-3-piperidine Carboxylic Acid], a Novel Histamine H1 Receptor Antagonist, Produces Potent and Selective Antinociceptive Effects on Dorsal Horn Neurons after Inflammation and Neuropathy
    R. Suzuki, M. Edwards and A. H. Dickenson
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1230-1238; DOI: https://doi.org/10.1124/jpet.103.063511

TOXICOLOGY

  • You have access
    Protective Peptides That Are Orally Active and Mechanistically Nonchiral
    Douglas E. Brenneman, Catherine Y. Spong, Janet M. Hauser, Daniel Abebe, Albert Pinhasov, Tania Golian and Illana Gozes
    Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 1190-1197; DOI: https://doi.org/10.1124/jpet.103.063891
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 309 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 309, Issue 3
1 Jun 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • PERSPECTIVES IN PHARMACOLOGY
  • ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION AND IMMUNOPHARMACOLOGY
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • SEP-363856, a Novel, Non-D2 Psychotropic Agent
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics